The Australian sponsor of the so-called ‘morning after pill’, Postinor-2, has applied to the National Drugs and Poisoning Schedule Committee for a change in the scheduling of Postinor-2 (levonorgestrel) 0.75mg tablets in pack of two tablets from Schedule 4 (prescription only medicine) to Schedule 3 (pharmacist only medicine). The Committee will consider this application at its meeting on June 17-19, 2003.There are serious risks associated with the use of levonorgestrel in such doses (two tablets…
